Newly approved drug for infant respiratory distress syndrome
Wednesday, March 7, 2012 - 11:30
in Health & Medicine
Scientific advances have led to a new drug Surfaxin® (lucinactant), just approved by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.